Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
06/2005
06/23/2005WO2004095061A3 Solid-state beta detector for microfluidic devices
06/23/2005WO2004055026A8 Tetracyclic 3-substituted indoles having serotonin receptor affinity
06/23/2005US20050136498 Using pregnancy-associated plasma protein-A (PAPP-A) as diagnostic indicator of cardiovascular and atherosclerotic disorders
06/23/2005US20050136125 Exposure to oxygen antagonist in vivo; organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer
06/23/2005US20050136064 Liposomal composition composed of pre-formed liposomes having entrapped therapeutic agent and plurality of targeting conjugates composed of lipid, hydrophilic polymer and targeting ligand; target-cell sensitized liposome composition formed by incubating liposomal composition with selected conjugate
06/23/2005US20050136008 Polybiotin compounds for magnetic resonance imaging and drug delivery
06/23/2005US20050136003 Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use
06/23/2005US20050136002 Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters
06/23/2005US20050136001 Fluorinated carbohydrate conjugates
06/23/2005CA2546057A1 Method to improve the efficacy of therapeutic radiolabeled drugs
06/22/2005EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
06/22/2005EP1542734A1 Isotopically labelled indolinone derivatives and process for their preparation
06/22/2005EP0973554B1 Chelating agents
06/22/2005CN1630530A Polyalkylene polymer compounds and uses thereof
06/21/2005US6908903 Cluster clearing agents
06/21/2005US6908598 Rubidlum-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets
06/16/2005WO2005054128A2 Method and apparatus for synthesis of [11c] phosgen using concentrated [11c] carbon monoxide with uv light
06/16/2005WO2005053752A2 Novel imaging agents comprising caspase-3 inhibitors
06/16/2005WO2005033652A3 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
06/16/2005WO2005023180A3 Method for detecting cancer cells and monitoring cancer therapy
06/16/2005WO2004069159A3 Vitamin receptor binding drug delivery conjugates
06/16/2005WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof
06/16/2005US20050131223 Method for preparing radiolabeled thymidine having low chromophoric byproducts
06/16/2005US20050130274 Enzymatic process for the synthesis of organo-fluorine compounds
06/16/2005US20050130167 Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
06/16/2005US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation
06/16/2005US20050129619 N2S2 chelate-targeting ligand conjugates
06/16/2005US20050129615 Non-invasive system for detecting skin cancer
06/16/2005US20050129613 Mixing radioactive Technetium ethylenedicystiene complex with N-[2-(1H-pyrrolylmethyl)]-N'-(4-penten-3on-2)-ethane-1,2-diamine, and incubating
06/16/2005US20050129612 competitive binding assays useful in identification of enzyme inhibitors, used for the treatment of neurological disorders such as Alzheimer's disease
06/16/2005US20050129611 Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases
06/16/2005US20050129610 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor
06/16/2005CA2547236A1 Imaging agents comprising caspase-3 inhibitors
06/15/2005EP1539818A2 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
06/15/2005EP1539252A2 Blood clot-targeted nanoparticles
06/15/2005EP1539250A1 Radioactively labelled amino acid analogues, their preparation and use
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
06/15/2005EP1539207A1 Treatment of cell proliferative disorders with chlorotoxin
06/15/2005EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
06/15/2005CN1628114A Coumarines useful as biomarkers
06/15/2005CN1627962A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
06/14/2005US6906050 With various substitutents in the 12- and 17-positions of the porphyrin skeleton; atherosclerosis, restenosis
06/14/2005US6906031 Polyacid glycopeptide derivatives
06/14/2005US6905671 Using isotope of 5-aminolevulinic acid
06/14/2005US6905668 Diagnostic agents for pancreatic exocrine function
06/09/2005WO2005051948A1 Radioactive tropane alkaloid derivative, tropane alkaloid derivative, and process for producing them
06/09/2005WO2005051424A1 Targeting of erb antigens
06/09/2005WO2005051416A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications
06/09/2005WO2005051315A2 On-demand cleavable linkers for radioconjugates for cancer imaging and therapy
06/09/2005WO2005023177A3 Human monoclonal antibodies against bacillusanthracis protective antigen
06/09/2005WO2005023096A3 Methods and compositions for ultrasound imaging of apoptosis
06/09/2005WO2005016387A3 Dna-dependent mri contrast agents
06/09/2005US20050124844 Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
06/09/2005US20050124549 Method of modulating the proliferation of medullary thyroid carcinoma cells
06/09/2005US20050124005 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations
06/09/2005US20050123981 Using gastrointestinal specific genes (GSG) as tools in detection of cell proliferative disorders; immunodiagnostics; immunohistochemistry
06/09/2005US20050123552 Anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin
06/09/2005US20050123540 administering synergistic antibodies for treatment of lymphocytic lymphomas and leukemia; immunotherapy
06/09/2005US20050123477 Benzothiazole derivatives for in vivo imaging of amloid plaques
06/09/2005US20050123476 Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
06/09/2005US20050123473 Diagnosis, therapy, image of celluloar disorders; antitumor agents
06/09/2005CA2547435A1 Targeting of erb antigens
06/09/2005CA2546675A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications
06/08/2005EP1536844A2 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
06/08/2005EP1536843A2 Radiolabeled compounds and liposomes and their methods of making and using the same
06/08/2005EP1536818A2 Fibrinogen binding moieties
06/08/2005EP1069919B1 Stimulus sensitive gel comprising a radioisotope and methods of making such gel
06/07/2005US6903070 Mixtures of peptide antibiotics and cyclodextrins used for prophylaxis of bacterial infections in humans
06/07/2005US6902890 Method of diagnosing monitoring, staging, imaging and treating cancer
06/07/2005US6902719 Administering a reverse tracer of labeled glucose, unlabeled lactose to a patient and assessing labeled carbon dioxide in breath or blood; if the lactose is digested, labeled CO2 produced by labeled glucose, diluted by metabolism of lactose
06/07/2005US6902718 Such as methionine and radiolabelled somatostatin receptor-binding peptide depreotide; for increasing shelf-life/storage stability; medical diagnosis
06/02/2005WO2005049096A2 Protein and polymer conjugates as chelants with enhanced blood retention
06/02/2005WO2005049095A2 Contrast agent imaging angiotensin ii receptors
06/02/2005WO2005049005A1 Inhibitor imaging agents
06/02/2005WO2005048822A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
06/02/2005WO2005048810A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
06/02/2005WO2005026325A3 Bivalent targeting of cell surfaces
06/02/2005WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
06/02/2005US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors
06/02/2005US20050118105 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
06/02/2005US20050118100 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
06/02/2005US20050118099 Thiol-mediated drug attachment to targeting peptides
06/02/2005US20050118098 Radioactive ion
06/02/2005CA2747871A1 Compositions and methods for the treatment of tumor of hematopoietic origin
06/02/2005CA2546237A1 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
06/02/2005CA2545267A1 Inhibitor imaging agents
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
06/01/2005EP1534347A2 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005CN1622832A Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
06/01/2005CN1622830A Peptide-based compounds
06/01/2005CN1622754A Novel immune effect compound
06/01/2005CN1621407A Diphosphonic acid derivative, radioactive 99mTc labeled diphosphonic acid derivative and uses thereof
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
05/2005
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/26/2005WO2005046733A1 Contrast agent for medical imaging techniques and usage thereof
05/26/2005WO2005046449A2 Soluble tcr molecules and methods of use
05/26/2005WO2005010048A3 Rg1 antibodies and uses thereof
05/26/2005WO2004100490A3 Device and method for the fluorination of nucleophiles
05/26/2005WO2004093652A3 System and method for synthesis of molecular imaging probes including fdg